These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

71 related items for PubMed ID: 2247494

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Systemic inhibition of tumor growth by soluble Flk-1 gene therapy combined with cisplatin.
    Wang R, Zhang XW, Wang GQ, Chen XC, Tian L, Yang HS, Hu M, Peng F, Yang JL, He QM, Zhang W, Jiang Y, Deng HX, Wen YJ, Li J, Zhao X, Wei YQ.
    Cancer Gene Ther; 2006 Oct; 13(10):940-7. PubMed ID: 16799469
    [Abstract] [Full Text] [Related]

  • 3. [Experimental studies on anti-tumor effects of BLC-modified tumor cell vaccine combined with cisplatin].
    Zou CH, Tian L, Wei YQ, Zhao X, Kan B, Yang JL, Mao YQ, Wen YJ, Li J, Deng HX.
    Ai Zheng; 2004 Jan; 23(1):1-7. PubMed ID: 14720366
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Combination of MIG (CXCL9) chemokine gene therapy with low-dose cisplatin improves therapeutic efficacy against murine carcinoma.
    Zhang R, Tian L, Chen LJ, Xiao F, Hou JM, Zhao X, Li G, Yao B, Wen YJ, Li J, Zhang L, Chen XC, Luo F, Peng F, Jiang Y, Wei YQ.
    Gene Ther; 2006 Sep; 13(17):1263-71. PubMed ID: 16672984
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A critical role for a peritumoral stromal reaction in the induction of T-cell migration responsible for interleukin-12-induced tumor regression.
    Ogawa M, Umehara K, Yu WG, Uekusa Y, Nakajima C, Tsujimura T, Kubo T, Fujiwara H, Hamaoka T.
    Cancer Res; 1999 Apr 01; 59(7):1531-8. PubMed ID: 10197625
    [Abstract] [Full Text] [Related]

  • 11. Vascular endothelial growth factor blockade reduces intratumoral regulatory T cells and enhances the efficacy of a GM-CSF-secreting cancer immunotherapy.
    Li B, Lalani AS, Harding TC, Luan B, Koprivnikar K, Huan Tu G, Prell R, VanRoey MJ, Simmons AD, Jooss K.
    Clin Cancer Res; 2006 Nov 15; 12(22):6808-16. PubMed ID: 17121902
    [Abstract] [Full Text] [Related]

  • 12. Enhancement of cisplatin sensitivity of quiescent cells in solid tumors by combined treatment with tirapazamine and low-temperature hyperthermia.
    Masunaga S, Ono K, Hori H, Akaboshi M, Kawai K, Suzuki M, Kinashi Y, Kasai S, Nagasawa H, Uto Y.
    Radiat Med; 1998 Nov 15; 16(6):441-8. PubMed ID: 9929144
    [Abstract] [Full Text] [Related]

  • 13. Combined therapy of mice bearing a lymphokine-activated killer-resistant tumor with recombinant interleukin 2 and an antitumor monoclonal antibody capable of inducing antibody-dependent cellular cytotoxicity.
    Kawase I, Komuta K, Hara H, Inoue T, Hosoe S, Ikeda T, Shirasaka T, Yokota S, Tanio Y, Masuno T.
    Cancer Res; 1988 Mar 01; 48(5):1173-9. PubMed ID: 3257715
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Lovastatin potentiates antitumor activity and attenuates cardiotoxicity of doxorubicin in three tumor models in mice.
    Feleszko W, Mlynarczuk I, Balkowiec-Iskra EZ, Czajka A, Switaj T, Stoklosa T, Giermasz A, Jakóbisiak M.
    Clin Cancer Res; 2000 May 01; 6(5):2044-52. PubMed ID: 10815931
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Chemo-immunotherapeutical studies on Dalton's lymphoma in mice using cisplatin and ascorbic acid: synergistic antitumor effect in vivo and in vitro.
    Sarna S, Bhola RK.
    Arch Immunol Ther Exp (Warsz); 1993 May 01; 41(5-6):327-33. PubMed ID: 8010874
    [Abstract] [Full Text] [Related]

  • 20. The in vivo effect of bryostatin-1 on paclitaxel-induced tumor growth, mitotic entry, and blood flow.
    Koutcher JA, Motwani M, Zakian KL, Li XK, Matei C, Dyke JP, Ballon D, Yoo HH, Schwartz GK.
    Clin Cancer Res; 2000 Apr 01; 6(4):1498-507. PubMed ID: 10778982
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.